Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

SYK | Stryker Corp.

IndexS&P 500 P/E37.57 EPS (ttm)7.08 Insider Own6.49% Shs Outstand378.70M Perf Week-2.81%
Market Cap100.97B Forward P/E23.18 EPS next Y11.47 Insider Trans-0.03% Shs Float355.13M Perf Month-6.53%
Income2.71B PEG3.73 EPS next Q2.44 Inst Own79.16% Short Float / Ratio1.04% / 2.87 Perf Quarter-10.59%
Sales19.45B P/S5.19 EPS this Y11.04% Inst Trans1.53% Short Interest3.69M Perf Half Y-7.54%
Book/sh45.71 P/B5.82 EPS next Y10.62% ROA7.38% Target Price320.72 Perf Year31.27%
Cash/sh3.89 P/C68.32 EPS next 5Y10.08% ROE16.40% 52W Range203.23 - 306.93 Perf YTD8.74%
Dividend2.41 P/FCF41.78 EPS past 5Y18.15% ROI9.38% 52W High-13.38% Beta0.95
Dividend %0.91% Quick Ratio0.84 Sales past 5Y8.44% Gross Margin59.93% 52W Low30.82% ATR6.44
Employees51000 Current Ratio1.54 Sales Q/Q11.20% Oper. Margin20.54% RSI (14)33.33 Volatility3.03% 2.22%
OptionableYes Debt/Eq0.77 EPS Q/Q12.00% Profit Margin13.92% Rel Volume1.56 Prev Close273.84
ShortableYes LT Debt/Eq0.66 EarningsAug 03 AMC Payout45.95% Avg Volume1.28M Price265.87
Recom1.97 SMA20-7.15% SMA50-6.26% SMA200-4.39% Volume2,002,259 Change-2.91%
Date Action Analyst Rating Change Price Target Change
Sep-05-23Upgrade BofA Securities Neutral → Buy $310 → $315
Mar-29-23Initiated UBS Neutral $287
Jan-25-23Initiated KeyBanc Capital Markets Sector Weight
Jan-09-23Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $284
Nov-01-22Downgrade Canaccord Genuity Buy → Hold $225 → $220
Oct-18-22Initiated Barclays Overweight $239
Oct-12-22Initiated Jefferies Buy $270
Jul-28-22Upgrade Edward Jones Hold → Buy
Jul-21-22Downgrade Deutsche Bank Buy → Hold $285 → $205
Jul-11-22Downgrade BofA Securities Buy → Neutral $215
Oct-02-23 04:05PM
Sep-29-23 04:05PM
Sep-28-23 07:03AM
Sep-26-23 12:33PM
11:40AM Loading…
Sep-25-23 11:40AM
Sep-22-23 09:49AM
Sep-21-23 07:06PM
Sep-19-23 09:20AM
Sep-18-23 12:39PM
Sep-15-23 12:05PM
08:03AM Loading…
Sep-14-23 08:03AM
Sep-13-23 08:37AM
Sep-12-23 09:20AM
Sep-11-23 07:18PM
Sep-09-23 01:02AM
Sep-07-23 11:40AM
Sep-06-23 01:48AM
Sep-04-23 07:45AM
Sep-01-23 03:29PM
Aug-28-23 09:58AM
Aug-22-23 05:26PM
07:04AM Loading…
Aug-09-23 07:04AM
Aug-08-23 01:26PM
Aug-07-23 04:05PM
Aug-04-23 04:40PM
Aug-03-23 10:22PM
Aug-02-23 06:05PM
Aug-01-23 07:29AM
Jul-31-23 08:46AM
Jul-27-23 07:07PM
Jul-25-23 08:59AM
Jul-19-23 11:40AM
Jul-15-23 07:06AM
Jul-12-23 09:01AM
Jul-11-23 10:17AM
Jul-10-23 06:24AM
Jul-06-23 08:27AM
Jul-03-23 09:04AM
Jun-30-23 04:05PM
Jun-29-23 06:54PM
Jun-27-23 01:31PM
Jun-26-23 11:38AM
Jun-22-23 10:07AM
Jun-21-23 11:40AM
Jun-19-23 07:30AM
Jun-15-23 07:32AM
Jun-14-23 04:10PM
Jun-05-23 11:40AM
May-31-23 11:30AM
May-30-23 08:03AM
May-26-23 04:17PM
May-25-23 07:20AM
May-24-23 08:30AM
May-22-23 04:15PM
May-18-23 11:40AM
May-12-23 10:22AM
May-11-23 06:14PM
May-10-23 01:01PM
May-09-23 07:07AM
May-08-23 08:36AM
May-05-23 09:59AM
May-04-23 03:00PM
May-03-23 10:07AM
May-02-23 11:49AM
Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Menon VijuGroup PresidentSep 06Sale289.005,0001,445,0006,994Sep 08 04:20 PM
Datar Srikant M.DirectorAug 10Sale286.23750214,6716,066Aug 10 04:24 PM
Datar Srikant M.DirectorAug 08Option Exercise93.062,000186,1207,467Aug 10 04:24 PM
Datar Srikant M.DirectorJun 01Sale278.50500139,2505,467Jun 05 05:24 PM
Datar Srikant M.DirectorMay 18Sale286.001,000286,0005,967May 19 06:29 PM
Caforio GiovanniDirectorMay 04Option Exercise0.0084101,850May 08 04:29 PM
BRAINERD MARY KDirectorMay 04Option Exercise0.0084105,110May 08 04:22 PM
Suri RajeevDirectorMay 04Option Exercise0.0084104,510May 08 04:45 PM
Skeete Tatum Lisa MDirectorMay 04Option Exercise0.0084102,525May 08 04:40 PM
McCoy Sherilyn SDirectorMay 04Option Exercise0.0084104,510May 08 04:34 PM
Boehnlein Glenn SVP, Chief Financial OfficerMar 21Option Exercise0.0014907,902Mar 23 06:47 PM
STRYKER RONDA EDirectorMar 21Option Exercise0.001,04802,582Mar 23 07:16 PM
Stiles Spencer SGroup PresidentMar 21Option Exercise0.00107045,413Mar 23 07:11 PM
Pierce James AndrewGroup PresidentMar 21Option Exercise0.00107050,610Mar 23 07:07 PM
Menon VijuGroup PresidentMar 21Option Exercise0.0088013,861Mar 23 07:03 PM
Lobo KevinChair and CEOMar 21Option Exercise0.00504099,253Mar 23 07:00 PM
Fletcher Robert SVP, Chief Legal OfficerMar 21Option Exercise0.006509,030Mar 23 06:56 PM
Fink M KathrynVP, Chief HR OfficerMar 21Option Exercise0.0046010,974Mar 23 06:52 PM
Becker Yin CVP, Chief Corp Affairs OfficerMar 21Option Exercise0.0022022,496Mar 23 06:36 PM
Golston Allan C.DirectorFeb 28Option Exercise86.698,150706,52721,687Mar 01 05:47 PM
Golston Allan C.DirectorFeb 28Sale263.275,4591,437,18013,537Mar 01 05:47 PM
Menon VijuGroup PresidentFeb 09Sale264.312,161571,16610,611Feb 13 05:35 PM
STRYKER RONDA EDirectorFeb 07Sale271.21212,20057,551,5454,730,754Feb 08 07:08 PM
STRYKER RONDA EDirectorFeb 06Sale273.91307,80084,308,7004,942,954Feb 08 07:08 PM
Fletcher Robert SVP, Chief Legal OfficerFeb 03Sale283.543,000850,6106,636Feb 06 06:21 PM
Pierce James AndrewGroup PresidentFeb 02Option Exercise64.0112,500800,12554,204Feb 06 06:26 PM
Berry William E JrVP, Chief Accounting OfficerFeb 02Option Exercise93.067,415690,04011,056Feb 06 06:13 PM
STRYKER RONDA EDirectorFeb 02Option Exercise64.015,520353,3357,054Feb 06 06:30 PM
Becker Yin CVP, Chief Corp Affairs OfficerFeb 02Option Exercise64.014,885312,68924,096Feb 06 06:08 PM
Boehnlein Glenn SVP, Chief Financial OfficerFeb 02Sale278.5424,4256,803,3562,428Feb 06 06:17 PM
Berry William E JrVP, Chief Accounting OfficerFeb 02Sale279.794,0581,135,3702,886Feb 06 06:13 PM
Pierce James AndrewGroup PresidentFeb 02Sale277.88400111,15246,676Feb 06 06:26 PM
Boehnlein Glenn SVP, Chief Financial OfficerJan 11Option Exercise64.0114,515929,10535,286Jan 12 07:30 PM
Fink M KathrynVP, Chief HR OfficerJan 11Sale257.696,5711,693,3099,264Jan 11 07:02 PM
Fink M KathrynVP, Chief HR OfficerJan 10Option Exercise95.886,571630,02015,835Jan 11 07:02 PM
Fink M KathrynVP, Chief HR OfficerJan 09Sale260.003,536919,3609,264Jan 11 07:02 PM
Datar Srikant M.DirectorDec 07Sale240.251,000240,2556,262Dec 07 04:07 PM
Datar Srikant M.DirectorDec 05Option Exercise81.144,355353,3659,216Dec 07 04:07 PM
Datar Srikant M.DirectorDec 05Sale238.70500119,3487,262Dec 07 04:07 PM
Lobo KevinChair and CEODec 02Option Exercise64.01187,47011,999,955268,240Dec 05 07:09 PM
Lobo KevinChair and CEODec 02Sale239.6867,23216,114,29980,770Dec 05 07:09 PM
Becker Yin CVP, Chief Corp Affairs OfficerNov 16Option Exercise64.014,885312,68922,139Nov 18 04:21 PM
Datar Srikant M.DirectorNov 07Sale212.3630063,7074,861Nov 08 08:22 PM
Datar Srikant M.DirectorNov 02Sale216.71600130,0265,161Nov 04 04:18 PM
Fink M KathrynVP, Chief HR OfficerNov 02Sale219.6834074,69112,774Nov 03 04:49 PM